Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

NCT01383668 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of access to study drug

Conditions

Recurrent Non-small Cell Lung Cancer
Squamous Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: sirolimus
DRUG: gold sodium thiomalate
OTHER: pharmacological study
GENETIC: RNA analysis
GENETIC: polymerase chain reaction

Sponsor

Mayo Clinic

Collaborators

[object Object]